Optometrists in Herkimer, NY Accepting Medicare
6 Optometrists found. Showing 1 - 6
 Dale K Meyer Optometrist Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, Post Office Box 188, Herkimer, NY 13350 Phone: 315-866-7784 Fax: 315-866-7785 |
Herkimer Eyecare Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 394 E State St, Herkimer, NY 13350 Phone: 315-866-9667 Fax: 315-866-9668 |
 Dr. Andrew S Luck, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3079 State Route 28, Herkimer, NY 13350 Phone: 315-866-4020 Fax: 315-866-4026 |
Donald Knapp Optometrist Medicare: Not Enrolled in Medicare Practice Location: 107 N Prospect St, Herkimer, NY 13350 Phone: 315-866-3751 Fax: 315-866-3751 |
 Dr. Judith E Golden, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3079 State Route 28, Herkimer, NY 13350 Phone: 315-866-4020 Fax: 315-866-4026 |
Drs Luck & Golden Optometrists Pc Optometrist Medicare: Medicare Enrolled Practice Location: 3079 State Route 28, Herkimer, NY 13350 Phone: 315-866-4020 Fax: 315-866-4026 |
News Archive
GlobalPost series examines consequences of child marriage in Nepal
As part of a special report called "Child Brides," GlobalPost features a two-part series looking at child marriage in Nepal. "The practice carries with it devastating consequences for young girls' health and wellbeing, child advocates say, and yet the social, economic and cultural pressures associated with the tradition make it difficult to end. Officially, it is against the law to marry under the age of 20, but these laws go ignored, particularly in remote areas.
Karolinska Institutet researchers find solutions for nerve stimulation
Researchers at Karolinska Institutet have developed a method for producing flexible plastic electrodes capable of releasing the neurotransmitter acetylcholine upon an electrical trigger.
Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma
Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) with or without VELCADE® (bortezomib) for Injection for patients with a common type of lymphoma. The study will examine previously untreated patients with a genomically defined subtype of lymphoma called non-germinal center B-cell-like (non-GCB) diffuse large B-cell lymphoma.
NEB announces introduction of one-step cloning and multiple DNA fragment assembly
New England Biolabs announces the introduction of the NEBuilder HiFi DNA Assembly Cloning Kit and Master Mix for one-step cloning and multiple DNA fragment assembly in as little as 15 minutes.
› Verified 9 days ago
Physical Therapists
Occupational Therapists
Chiropractors
Optometrists
Speech-Language Pathologists
Podiatrists